Browsing by 저자 : Jae Ho Jeong
전체 결과 25건 중 1-25 번을 표시중입니다.
- 1 Article A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index Giulia Rovesti ; Francesco Leone ; Giovanni Brandi ; et al 2022
- 2 Article A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIOR Jwa Hoon Kim ; Changhoon Yoo ; Seyoung Seo ; et al 2022
- 3 Article Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial Hyehyun Jeong ; Kyu-Pyo Kim ; Jae Ho Jeong ; et al 2023
- 4 Article Antibody-drug conjugates targeting Trop-2: Clinical developments in early breast cancer therapy Jae Ho Jeong ; Sung-Bae Kim 2022
- 5 Article Breast cancer outcomes following immediate breast reconstruction with implants versus autologous flaps: a propensity score-matched study Zhen-Yu Wu ; Jing Han ; Hee Jeong Kim ; et al 2022
- 6 Article Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16) Se Hyun Kim ; Seock-Ah Im ; Koung Jin Suh ; et al 2023
- 7 Article Comparison of the Effectiveness and Clinical Outcome of Everolimus Followed by CDK4/6 Inhibitors with the Opposite Treatment Sequence in Hormone Receptor?Positive, HER2-Negative Metastatic Breast Cancer Hyehyun Jeong ; Jae Ho Jeong ; Jeong Eun Kim ; et al 2022
- 8 Article CT Findings From Interstitial Lung Diseases in Patients With Metastatic Breast Cancer Treated With Fam-Trastuzumab Deruxtecan: A Single Institutional Experience Yoon Jung Jang ; Jae Ho Jeong ; Jeong Eun Kim ; et al 2022
- 9 Article Domestic medical travel from non-Seoul regions to Seoul for initial breast cancer treatment: a nationwide cohort study Jae Ho Jeong ; Jinhong Jung ; Hee Jeong Kim ; et al 2023
- 10 Article Epithelial-Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer Chung Ryul Oh ; Hyung-Don Kim ; Yeon-Mi Ryu ; et al 2023
- 11 Article Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer Changhwan Sung ; Jinhyeon An ; Soohyeon Lee ; et al 2023
- 12 Article Knowledge, attitudes, and behaviors toward fertility preservation in patients with breast cancer: A cross-sectional survey of physicians Soo Yeon Baek ; Kyung-Hun Lee ; Sung-Bae Kim ; et al 2023
- 13 Article Oncologic outcomes of immediate breast reconstruction in young women with breast cancer receiving neoadjuvant chemotherapy Zhen-Yu Wu ; Hee Jeong Kim ; Jongwon Lee ; et al 2022
- 14 Article Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer Sora Kang ; So Heun Lee ; Hee Jin Lee ; et al 2023
- 15 Article Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index Giulia Rovesti ; Francesco Leone ; Giovanni Brandi ; et al 2022
- 16 Article Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment of three cycles of FEC followed by three cycles of docetaxel (FEC3-D3) in node-positive breast cancer (Neo-shorter; NCT02001506) Inhwan Hwang ; Jeong Eun Kim ; Jae Ho Jeong ; et al 2023
- 17 Article Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma Sora Kang ; Changhoon Yoo ; So Heun Lee ; et al 2022
- 18 Article Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group Shinkyo Yoon ; Miso Kim ; Yong Sang Hong ; et al 2022
- 19 Article Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer Hee Kyung Ahn ; Sung Hoon Sim ; Koung Jin Suh ; et al 2022
- 20 Article Stereotactic Body Radiation Therapy versus Concurrent Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Propensity Score-Matched Analysis Young Seob Shin ; Hee Hyun Park ; Jin-hong Park ; et al 2022
- 21 Article Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX So Heun Lee ; Dae Wook Hwang ; Changhoon Yoo ; et al 2023
- 22 Article The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study Jwa Hoon Kim ; Seyoung Seo ; Jee Hyun Kim ; et al 2022
- 23 Article Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer The Phase 2b NIFTY Randomized Clinical Trial Jaewon Hyung ; Ilhwan Kim ; Kyu-pyo Kim ; et al 2023
- 24 Article Waiting Time for Breast Cancer Treatment in Korea: A Nationwide Cohort Study Young-jin Lee ; Jae Ho Jeong ; Jinhong Jung ; et al 2023
-
25
dissertation
건강보험 심사평가원 청구 자료를 이용한 유방암 치료를 위한 국내 의료 여행에 관한 연구
정재호
2022
1